Diagnosis of latent polycythemia vera: A clinician’s opinion

Abstract

Aim. To identify the clinical features of latent polycythemia vera (PV) as an independent nosological entity. Subjects and methods. The investigation enrolled 81 patients (50 with extensive (manifest) PV and 31 with latent PV) who had visited the Outpatient Department, Hematology Research Center, Ministry of Health of Russia, in 2014 to October 2015. Results. The gender distribution of the patients was statistically comparable in the analyzed groups. The patients with manifest PV were slightly older than those with latent PV: the median age in the compared groups was 56 and 44 years, respectively. Red blood cell counts, hemoglobin concentrations, and packed cell volume were higher in the patients with manifest PV. Blood platelet counts were higher in the latent PV group. There were no differences in the number of white blood cells in the compared groups. All the patients were JAK2 V617F mutation carriers. The JAK2 allele load was significantly higher in the manifest PV group than in the latent PV group. The compared patient groups differed in the rate of thromboses in the history or at diagnosis. In the patients with latent PV, thromboses were detected in 38% of cases versus 16% in those with manifest PV. In latent PV, there were mainly venous thromboses; abdominal vascular thromboses were diagnosed with a high frequency. Arterial thromboses were revealed in only 2 cases. Conclusion. Chronic myeloproliferative disease that is characterized by the JAK2 V617F mutation, borderline hemoglobin counts, and morphological features of a bone marrow trephine biopsy specimen, which are specific for PV, is an independent PV variant, namely: latent PV.

References

  1. Меликян А.Л., Туркина А.Г., Абдулкадыров К.М., Зарицкий А.Ю., Афанасьев Б.В., Шуваев В.А., Ломаиа Е.Г., Морозова Е.В., Байков В.В., Голенков А.К., Суборцева И.Н., Соколова М.А., Ковригина А.М., Мартынкевич И.С., Грицаев С.В., Судариков А.Б., Суханова Г.А., Иванова В.Л., Капланов К.Д., Константинова Т.С. Клинические рекомендации по диагностике и терапии Ph-негативных миелопролиферативных заболеваний (истинная полицитемия, эссенциальная тромбоцитемия, первичный миелофиброз). Гематология и трансфузиология. 2014;59(4):31-56.
  2. Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, Harris NL, Le Beau MM, Hellström-Lindberg E, Tefferi A, Bloomfield CD. The 2008 revision of the WHO classification of myeloid neoplasms and acute leukemia: Rationale and important changes. Blood. 2009;114:937-951. doi: 10.1182/blood-2009-03-209262
  3. McMullin MF, Bareford D, Campbell P, Green AR, Harrison C., Hunt B, Oscier D, Polkey MI, Reilly JT, Rosenthal E, Ryan K, Pearson TC, Wilkins B. Guidelines for the diagnosis, investigation and management of polycythemia/erythrocytosis. Br J Haematol. 2005;130:174-195.
  4. Johansson PL, Safai-Kutti S, Kutti J. An elevated venous haemoglobin concentration cannot be used as a surrogate marker for absolute erythrocytosis: A study of patients with polycythaemia vera and apparent polycythaemia. Br J Haematol. 2005;129:701-705. doi: 10.1111/j.1365-2141.2005.05517.x
  5. Alvarez-Larran A, Anchocea A, Angona A, Pedro C, García-Pallarols F, Martínez-Avilés L, Bellosillo B, Besses C. Red cell mass measurement in patients with clinically suspected diagnosis of polycythemia vera or essential thrombocythemia. Haematologica. 2012;97:1704-1707. doi: 10.1002/ajh.23585
  6. Silver RT, Chow W, Vandris K, Tam I, Narayan A, De Sancho M T, Orazi A, Goldsmit SJ. Prospective evaluation of the World Health Organization criteria for the diagnosis of polycythemia vera. Blood (ASH Annual Meeting Abstracts). 2011;118:3837.
  7. Ковалева Л.Г., Меликян А.Л., Ко П.И., Седова Г.Т., Петров М.М. Эритроцитаферез в комплексном лечении истинной полицитемии. Гематология и трансфузиология. 1987;32(11): 10-14.
  8. Barbui T, Thiele J, Gisslinger H, Finazzi G, Carobbio A, Rumi E, Luigia Randi M, Betozzi I, Vannucchi AM, Pieri L, Carrai V, Gisslinger B, Mullauer L, Ruggeri M, Rambaldi A, Tefferi A. Masked polycythemia Vera (mPV): Results of an international study. Am J Hematol. 2014;89:52-54. doi: 10.1002/ajh.23585
  9. Chu D, Cho Y-U, Jang S, Seo E-J, Park C-J. Straightforward Identification of Masked Polycythemia Vera Based on Proposed Revision of World Health Organization Diagnostic Criteria for BCR-ABL1-Negative Myeloproliferative Neoplasms. Ann Lab Med. 2015;35:651-653. doi: 10.3343/alm.2015.35.6.651
  10. Lussana F, Carobbio A, Randi ML, Elena C, Rumi E, Finazzi G, Bertozzi I, Pieri L, Ruggeri M, Palandri F, Polverelli N, Elli E, Tieghi A, Iurlo A, Ruella M, Cazzola M, Rambaldi A, Vannucchi AM, Barbui T. A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera. Br J Haematol. 2014 67(4):541-546. doi: 10.1111/bjh.13080
  11. Thiele J, Kvasnicka HM, Diehl V. Initial (latent) polycythemia vera with thrombocytosis mimicking essential thrombocythemia. Acta Haematol. 2005; 113:213-219.
  12. Gianelli U, Iurlo A, Vener C, Moro A, Fermo E, Bianchi P, Graziani D, Radaelli F, Coggi G, Bosari S, Deliliers GL, Zanella A. The significance of bone marrow biopsy and JAK2V617F mutation in the differential diagnosis between the «early» prepolycythemic phase of polycythemia vera and essential thrombocythemia. Am J Clin Pathol. 2008;30:336-342. doi: 10.1309/6BQ5K8LHVYAKUAF4
  13. Kvasnicka HM, Thiele J. Prodromal myeloproliferative neoplasms: The 2008 WHO classification. Am J Hematol. 2010;85:62-66. doi: 10.1002/ajh.21543
  14. Barbui T, Thiele J, Vannucchi AM, Tefferi A. Problems and pitfalls regarding WHO-defined diagnosis of early/prefibrotic primary myelofibrosis versus essential thrombocythemia. Leukemia. 2013;27(10):1953-1958. doi: 10.1038/leu.2013.74
  15. Madelung AB, Bondo H, Stamp I, Loevgreen P, Nielsen SL, Falensteen A, Knudsen H, Ehinger M, Dahl-Sørensen R, Mortensen NB, Svendsen KD, Lange T,Ralfkiaer E, Nielsen K, Hasselbalch HC, Thiele J. World Health Organization-defined classification of myeloproliferative neoplasms: Morphological reproducibility and clinical correlations-the Danish experience. Am J Hematol. 2013;88(12):1012-1016. doi: 10.1002/ajh.23554
  16. Barbui T, Thiele J, Passamonti F, Rumi E, Boveri E, Randi ML, Bertozzi I, Marino F, Vannucchi AM, Pieri L, Rotunno G, Gisslinger H, Gisslinger B, Müllauer L, Finazzi G, Carobbio A, Gianatti A, Ruggeri M, Nichele I, D’Amore E, Rambaldi A, Tefferi A. Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome. Blood. 2012;119(10):2239-2241. doi: 10.1182/blood-2011-11-393819
  17. Sirhan S, Fairbanks VF, Tefferi A. Red cell mass and plasma volumen measurements in polycythemia: Evaluation of performance and practical utility. Cancer. 2005;104(1):213-215.
  18. Tefferi A. Diagnosing polycythemia vera: A paradigma shift. Mayo Clin Proc. 1999;74(2):159-162.
  19. Mossuz P, Girodon F, Donnand M, Latger-Cannard V, Dobo I, Boiret N, Lecron JC, Binquet C, Barro C, Hermouet S, Praloran V. Diagnostic value of serum erythropoietin level in patients with absolute erythrocytosis. Haematologica. 2004;89(10);1194-1198.
  20. Barbui T, Thiele J, Vannucchi AM, Tefferi A. Rethinking the diagnostic criteria of polycythemia vera. Leukemia. 2014;28:1191-1195.
  21. Меликян А.Л., Суборцева И.Н. Материалы 19-го конгресса европейской гематологической ассоциации (2014 г., Милан) Клиническая онкогематология. Фундаментальные исследования и клиническая практика. 2014;7(4):598-607.
  22. Суборцева И.Н., Колошейнова Т.И., Пустовая Е.И., Егорова Е.К., Ковригина А.М., Плискунова Ю.В., Макарик Т.В., Абдуллаев А.О., Меликян А.Л. Истинная полицитемия: обзор литературы и собственные данные. Клиническая онкогематология. Фундаментальные исследования и клиническая практика. 2015;8(4):598-607.
  23. Barbui T, Thiele J, Carobbio A, Gisslinger H, Finazzi G, Rumi E, Luigia Randi M, Vannucchi AM, Gisslinger B, Müllauer L, Ruggeri M, Rambaldi A, Tefferi A. Masked polycythemia vera diagnosed according to WHO and BCSH classification. Am J Hematol. 2014;89:199-202. doi: 10.1002/ajh.23617
  24. Barbui T, Thiele J, Carobbio A, Guglielmelli P, Rambaldi A, Vannucchi AM, Tefferi A. Discriminating between essential thrombocythemia and masked polycythemia vera in JAK2 mutated patients. Am J Hematol. 2014;89:588-590. doi: 10.1002/ajh.23694
  25. Silver RT, Chow W, Orazi A, Arles SP, Goldsmith SJ. Evaluation of WHO criteria for diagnosis of polycythemia vera: a prospective analysis. Blood. 2013;122:1881-1886. doi: 10.1182/blood-2013-06-508416
  26. Tefferi A, Rumi E, Finazzi G, Gisslinger H, Vannucchi AM, Rodeghiero F, Randi ML, Vaidya R, Cazzola M, Rambaldi A, Gisslinger B, Pieri L, Ruggeri M, Bertozzi I, Sulai NH, Casetti I, Carobbio A, Jeryczynski G, Larson DR, Müllauer L, Pardanani A, Thiele J, Passamonti F, Barbui T. Survival and prognosis among 1545 patients with contemporary polycythemia vera: An international study. Leukemia. 2013;27(9):1874-1881. doi: 10.1038/leu.2013.163
  27. Barbui T, Barosi G, Birgegard G, Cervantes F, Finazzi G, Griesshammer M, Harrison C, Hasselbalch HC, Hehlmann R, Hoffman R, Kiladjian JJ, Kröger N, Mesa R, McMullin MF, Pardanani A, Passamonti F, Vannucchi AM, Reiter A, Silver RT, Verstovsek S, Tefferi A. Philadelphia-negative classical myeloproliferative neoplasms: Critical concepts and management recommendations from European Leukemia Net. J Clin Oncol. 2011;29(6): 761-770. doi: 10.1200/JCO.2010.31.8436
  28. Marchioli R, Finazzi G, Specchia G, Cacciola R, Cavazzina R, Cilloni D, De Stefano V, Elli E, Iurlo A, Latagliata R, Lunghi F, Lunghi M, Marfisi RM, Musto P, Masciulli A, Musolino C, Cascavilla N, Quarta G, Randi ML, Rapezzi D, Ruggeri M, Rumi E, Scortechini AR, Santini S, Scarano M, Siragusa S, Spadea A, Tieghi A, Angelucci E, Visani G, Vannucchi AM, Barbui T. Cardiovascular events and intensity of treatment in polycythemia vera. N Engl J Med. 2013;368(1):22-33. doi: 10.1056/NEJMoa1208500

Copyright (c) 2016 Melikian A.L., Subortseva I.N., Kovrigina A.M., Kolosheynova T.I., Abdullaev A.O., Kuznetsova P.I., Sudarikov A.B., Kulikov S.M.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

© 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies